Structural phase instability,mixed-phase,and energy band gap change in BiFeO3 under lattice strain effect from first-principles investigation

Lattice strain effects drive a variety of novel functional responses in epitaxial BiFeO₃ thin films and have attracted significant interest and attention from researchers in experimental and theoretical studies. However, the difficulty in designing experimental techniques in addition to facing problems in the first principles approach, such as output accuracy and high computational costs, constitute the discovery of new functional responses in epitaxial BiFeO₃ thin films not entirely understood. Therefore, in this study, we perform a first principles calculation based on the less expensive LDA+U method to investigate the structural phase instability and electronic properties change in BiFeO₃ under the lattice strain effect. The structural phase transformation of BiFeO₃ under volumetric and compressive/tensile lattice strain was examined established on the calculated lower energy phases. Importantly, we demonstrated that the change of crystal structure phases of BiFeO₃ was extremely sensitive to the volumetric and compressive/tensile lattice strain, comparable with various experiment data, as reported in the literature. Moreover, we revealed for the first time from the first principles prediction the coexistence of mixed R-T phases in the region of moderate compressive ζ_in-plane of ?2.9% (e.g. LaAlO₃ substrates with ɑ = 3.79 Å). From the prediction of electronic properties obtained by the LDA+U and PBE0 methods, we found that the energy band gap increased when the compressive in-plane lattice strain is increased while, in contrast, the energy band gap decreased when BiFeO₃ was under the tensile in-plane lattice strain effect. We also demonstrate that our computational technique based on the first principles study was sufficiently accurate enough, helping to speed up the process of designing new materials having an excellent multifunctional response (piezoelectric, magnetic, photovoltaic, spintronic).     

Insights into the in vitro Anticancer Effects of Diruthenium‐1

The in vitro anticancer activity of the dinuclear trithiolato‐bridged arene ruthenium complex diruthenium‐1 (DiRu‐1) was evaluated against a panel of human cancer cell lines used as in vitro models for hepatocellular carcinoma (HepG2 cells), estrogen‐responsive breast adenocarcinoma (MCF‐7 cells), and triple‐negative breast adenocarcinoma (MDA‐MB‐231 cells). DiRu‐1 is highly cytotoxic to these cell lines, demonstrating half‐maximal inhibitory concentrations (IC₅₀) in the low‐nanomolar range (77±1.4 to 268.2±4.4 nm ). The main molecular mechanisms responsible for the high cytotoxicity of DiRu‐1 against the most responsive MCF‐7 cell line (IC₅₀=77±1.4 nm) were investigated on the basis of the capacity of DiRu‐1 to induce oxidative stress, apoptosis, and DNA damage, and to inhibit the cell cycle and proliferation. The results show that DiRu‐1 triggers caspase‐dependent apoptosis in MCF‐7 cells on both the intrinsic and extrinsic pathways. Moreover, the Ru complex also causes necrosis, mitotic catastrophe, and autophagy. DiRu‐1 increases the intracellular levels of reactive oxygen species (ROS), which play a significant role in its cytotoxicity and pro‐apoptotic activity. An important mechanism of the anticancer activity of DiRu‐1 appears to be the induction of DNA lesions, mainly due to apoptotic DNA fragmentation and cell‐cycle arrest at the G₂/M checkpoint. These changes are correlated with the concentration of DiRu‐1, the duration of the cell treatment, and the post‐treatment time.